Prostate Cancer

News and new technology innovations concerning how imaging technology can help diagnose and treat prostate cancer can be found on this channel.

PET/CT, recurrent prostate cancer, fluciclovine F-18, Emory University

CTVPOST (red) = CTVPRE (yellow) union CTVPET (pink). Also shown (upper right corner) are the PRE (square) vs POST (triangle) dose volume histograms for PTV1, PTV2, rectum, bladder, and penile bulb, showing minimal impact on target coverage or organs at risk dose with the modified targets. Image courtesy of Ashesh B. Jani, M.D., and David Schuster, M.D., Emory University.

News | Radiopharmaceuticals and Tracers | March 16, 2017

March 16, 2017 — The featured clinical investigation article of the March 2017 issue of the ...

Michigan Medicine, Prostate Cancer Risk Clinic, first in the U.S.
News | Prostate Cancer | March 09, 2017

March 9, 2017 — Michigan Medicine and the University of Michigan have launched the nation’s first prostate cancer...

prostate cancer, radiation therapy, high-dose-rate brachytherapy, HDR, Red Journal study

This is a single-fraction high-dose-rate prostate implant imaging and dosimetry. Image courtesy of Daniel Krauss/American Society for Radiation Oncology (ASTRO)

News | Brachytherapy Systems | March 06, 2017

March 6, 2017 — Results from a new prospective clinical trial indicate high-dose-rate (HDR)...

Accuray, CyberKnife system, SBRT, long-term disease control, prostate cancer, ASCO GU study
News | Radiation Therapy | February 17, 2017

February 17, 2017 — Accuray Inc. recently announced data from a prospective, Phase II, 17-center study which showed...

ayDCE software, mpMRI, multiparametric magnetic resonance imaging, prostate MRI, RSNA 2017, AHRA, SIIM
Technology | Magnetic Resonance Imaging (MRI) | February 13, 2017

February 13, 2017 —  aycan recently introduced ayDCE software powered by aycan workstation. The new software helps...

Blue Earth Diagnostics, Axumin, fluciclovine F-18, recurrent prostate cancer, Simens PETNET Solutions, increased patient access
News | Radiopharmaceuticals and Tracers | February 07, 2017

February 7, 2017 — Blue Earth Diagnostics and Siemens’ PETNET Solutions announced that an increasing number of...

recurrent prostate cancer, hormone therapy, radiation therapy, Cedars-Sinai study, New England Journal of Medicine
News | Prostate Cancer | February 03, 2017

February 3, 2017 — Adding hormonal therapy to radiation treatment can significantly improve the average long-term...

PET/CT, primary and metastatic prostate cancer, Journal of Nuclear Medicine study, JNM

Ga-68-BBN PET/CT of a 64-year-old man newly diagnosed with prostate cancer by biopsy. Multiple bone metastasis lesions (arrows) were detected. Image courtesy of Jingjing Zhang, Peking Union Medical College, Beijing, China.

News | Prostate Cancer | February 02, 2017

February 2, 2017 — In the featured article from the February 2017 issue of the Journal of Nuclear Medicine,...

prostate cancer, PI-RADS, best clinical research paper, European Urology
News | Prostate Cancer | January 18, 2017

January 18, 2017 — An article promoting standardized imaging efforts to improve diagnosis and treatment of...

Augmenix, SpaceOAR hydrogel spacer, three-year trial data, Red Journal, prostate cancer radiotherapy
News | Patient Positioning Radiation Therapy | January 16, 2017

January 16, 2017 — Augmenix Inc. announced that the International Journal of Radiation Oncology Biology and Physics...

News | Radiopharmaceuticals and Tracers | January 06, 2017

January 6, 2017 — New research demonstrates that a novel...

MRI-guided focused ultrasound
News | Focused Ultrasound Therapy | December 22, 2016

Insightec Ltd. announced that the Exablate Prostate system received CE Mark for treating locally-confined prostate...

prostate, CT scan, Dave Fornell medical
News | Prostate Cancer | December 22, 2016

Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics...

News | Prostate Cancer | December 14, 2016

December 14, 2016 — Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on...

Exact Imaging Receives FDA 510(k) Clearance for Its ExactVu Micro-Ultrasound System
News | Prostate Cancer | December 09, 2016

Exact Imaging, a leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance...

prostate cancer, PET imaging, Johns Hopkins, Daniel Thorek, 11B6 antibody

Uptake of 89Zr-11B6 in the prostate of a transgenic mouse with prostate cancer. Image courtesy of Daniel Thorek

News | Prostate Cancer | November 30, 2016

November 30, 2016 — An international group of researchers report success in mice of a method of using...

Augmenix, SpaceOAR System, prostate cancer, new CPT code, AMA, American Medical Association
Technology | Prostate Cancer | November 10, 2016

November 10, 2016 — Augmenix Inc. announced that the American Medical Association (AMA) has granted a Category I,...

News | Prostate Cancer | November 02, 2016

November 2, 2016 — A new report on Swedish men with non-aggressive prostate cancer suggests a lot more American men...

Augmenix, SpaceOAR System, prostate cancer, three-year clinical data results, ASTRO 2016
News | Prostate Cancer | October 27, 2016

October 27, 2016 — Augmenix Inc. announced the three-year results from the SpaceOAR System...

intermediate-risk prostate cancer, brachytherapy versus external beam therapy, radiation therapy, RT, ASTRO 2016
News | Brachytherapy Systems | October 25, 2016

October 25, 2016 — For men with intermediate-risk...